THE MAGNA GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: C87006 | MEXBOROUGH, S64 5UP
Showing results 101-150 of 615
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mirabegron | 868 | 24.3K | £22.3K | +116.1% ▲ |
| Pravastatin sodium | 860 | 25.4K | £1.2K | +164.8% ▲ |
| Hyoscine butylbromide | 858 | 75.5K | £5.2K | +268.2% ▲ |
| 841 | 1,827 | £59.4K | +54.3% ▲ | |
| Sitagliptin | 838 | 24.3K | £1.8K | +114.9% ▲ |
| Diazepam | 824 | 27.3K | £701 | +65.4% ▲ |
| Levetiracetam | 822 | 62.2K | £6.6K | +79.6% ▲ |
| Flucloxacillin sodium | 815 | 30.9K | £1.8K | +81.2% ▲ |
| Memantine hydrochloride | 811 | 20.2K | £2.5K | +145.5% ▲ |
| Estradiol | 796 | 67.2K | £9.2K | -3.0% ▼ |
| Ferrous fumarate | 783 | 49.9K | £1.4K | +8.0% ▲ |
| Umeclidinium bromide/vilanterol | 776 | 779 | £24.1K | +297.9% ▲ |
| Umeclidinium bromide | 774 | 808 | £20.4K | +1,155.6% ▲ |
| Estradiol with progestogen | 755 | 16.3K | £19.7K | +121.5% ▲ |
| Morphine sulfate | 738 | 115.5K | £3.9K | +12.5% ▲ |
| Fluticasone propionate (Inhalation) | 725 | 763 | £19.1K | +87.4% ▲ |
| Nitrofurantoin | 725 | 10.8K | £7.1K | +51.9% ▲ |
| Loperamide hydrochloride | 724 | 46.5K | £1.3K | +210.9% ▲ |
| Esomeprazole | 715 | 28.8K | £1.8K | +76.7% ▲ |
| Methotrexate | 704 | 18.3K | £1.2K | +116.3% ▲ |
| Lactulose | 700 | 411.2K | £3.8K | +112.6% ▲ |
| 675 | 676 | £30.0K | +117.3% ▲ | |
| Diltiazem hydrochloride | 673 | 31.7K | £5.4K | +119.1% ▲ |
| Carbamazepine | 673 | 75.1K | £5.1K | +126.8% ▲ |
| Digoxin | 667 | 17.0K | £1.2K | +76.2% ▲ |
| Eplerenone | 664 | 16.7K | £2.1K | +150.4% ▲ |
| Carbomer 940/980 | 623 | 6,990 | £1.8K | +309.1% ▲ |
| Biphasic isophane insulin | 616 | 5,410 | £23.2K | +452.2% ▲ |
| Rivaroxaban | 603 | 17.8K | £12.3K | -1.4% vs avg |
| Risedronate sodium | 601 | 2,468 | £649 | +395.5% ▲ |
| Combined ethinylestradiol 30mcg | 598 | 49.4K | £2.2K | +115.3% ▲ |
| Letrozole | 597 | 14.5K | £1.3K | +219.7% ▲ |
| Paroxetine hydrochloride | 593 | 18.3K | £1.1K | +217.8% ▲ |
| Carbimazole | 582 | 20.9K | £5.8K | +415.2% ▲ |
| Cyanocobalamin | 582 | 27.3K | £3.6K | +64.9% ▲ |
| Insulin aspart | 575 | 4,589 | £26.6K | +51.0% ▲ |
| Dihydrocodeine tartrate | 566 | 43.8K | £2.8K | +189.7% ▲ |
| Timolol and bimatoprost | 557 | 6,240 | £8.4K | +267.0% ▲ |
| Quetiapine | 549 | 22.4K | £8.2K | -11.8% ▼ |
| Donepezil hydrochloride | 535 | 13.7K | £505 | +73.4% ▲ |
| Bumetanide | 528 | 20.3K | £5.8K | +93.8% ▲ |
| Mesalazine (Systemic) | 525 | 48.4K | £22.3K | +119.2% ▲ |
| Irbesartan | 525 | 14.1K | £649 | +115.5% ▲ |
| Topiramate | 524 | 29.0K | £3.9K | +194.8% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 518 | 518 | £7.3K | +356.7% ▲ |
| 516 | 540 | £3.1K | +118.4% ▲ | |
| Bisacodyl | 514 | 28.8K | £4.3K | +292.1% ▲ |
| Medroxyprogesterone acetate | 501 | 501 | £2.8K | +315.0% ▲ |
| Oxybutynin | 490 | 35.8K | £17.4K | +157.2% ▲ |
| Hydroxychloroquine sulfate | 490 | 26.0K | £1.3K | +153.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.